IMVT - Immunovant GAAP EPS of -$0.45 beats by $0.03
2023-11-09 08:01:02 ET
More on Immunovant
- Immunovant: Immune Boost, From Clinical Trials To An Aggressive Bullish Stock
- Immunovant: Data Sizzles, But The Steak Isn't Done Yet (Rating Upgrade)
- Immunovant, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Immunovant to raise $450M from public offering and private placement
- Immunovant stock rallies for second day, fueled by public offering, drug data
For further details see:
Immunovant GAAP EPS of -$0.45 beats by $0.03